{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:32:40Z","timestamp":1777275160112,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Major scientific and technological 1686 project in Tianjin: Clinical and industrialization of ginsenoside H dropping pills","award":["12ZCDZSY00400"],"award-info":[{"award-number":["12ZCDZSY00400"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.085","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T06:45:46Z","timestamp":1537857946000},"page":"865-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Combination of Ginsenoside H dripping pills and cyclophosphamide improve paraneoplastic syndrome and inhibit postoperative recurrence via the reversion of Th1\/Th2 shift"],"prefix":"10.1016","volume":"108","author":[{"given":"Fengfei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengtao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2018.09.085_bib0005","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.085_bib0010","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.4238\/2015.November.24.17","article-title":"Detection of CK19, LUNX, and KS1\/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications","volume":"14","author":"Yan","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"Suppl. 121","key":"10.1016\/j.biopha.2018.09.085_bib0015","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/cncr.29584","article-title":"Lung Cancer Group of Chinese Thoracic, C. Chinese Alliance Against Lung, Prevention and management of lung cancer in China","volume":"17","author":"Hong","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.085_bib0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JCO.2016.69.0834","article-title":"Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small-Cell lung Cancer: a competing risks analysis","volume":"35","author":"Eguchi","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.085_bib0025","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-487","article-title":"Paraneoplastic syndrome mimicking adult-onset Still\u2019s disease caused by advanced lung cancer: a case report","volume":"11","author":"Wu","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.085_bib0030","first-page":"231","article-title":"Characterization of a murine lung adenocarcinoma (LAC1), a useful experimental model to study progression of lung cancer","volume":"9","author":"Piegari","year":"2011","journal-title":"J. Exp. Ther. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.085_bib0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI115106","article-title":"Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice","volume":"87","author":"Yoneda","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.085_bib0040","first-page":"45","article-title":"Spontaneous murine lung adenocarcinoma (P07): a new experimental model to study paraneoplastic syndromes of lung cancer","volume":"2","author":"Diament","year":"1998","journal-title":"Int. J. Mol. Med."},{"issue":"34","key":"10.1016\/j.biopha.2018.09.085_bib0045","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1200\/JCO.2009.23.7420","article-title":"Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801","volume":"27","author":"Movsas","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.09.085_bib0050","article-title":"Ginsenoside Rg3 serves as an adjuvant chemotherapeutic agent and VEGF inhibitor in the treatment of non-small cell lung Cancer: a meta-analysis and systematic review","volume":"2016","author":"Xu","year":"2016","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.085_bib0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1470-2045(13)70604-1","article-title":"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial","volume":"15","author":"Wu","year":"2014","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.085_bib0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2012.2136","article-title":"Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells","volume":"29","author":"An","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.085_bib0065","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15039003","article-title":"JNK pathway and relative transcriptional factor were involved in ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells","volume":"15","author":"Liu","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.085_bib0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4161\/cbt.20557","article-title":"A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation","volume":"13","author":"Predina","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"18","key":"10.1016\/j.biopha.2018.09.085_bib0075","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1158\/0008-5472.CAN-08-1842","article-title":"Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism","volume":"68","author":"Stuelten","year":"2008","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.085_bib0080","first-page":"1303","article-title":"Depression, mood, stress, and Th1\/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy","volume":"19","author":"Krohn","year":"2011","journal-title":"Support. Care Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.085_bib0085","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3892\/ol.2014.2391","article-title":"Clinical significance of serum T helper 1\/T helper 2 cytokine shift in patients with non-small cell lung cancer","volume":"8","author":"Li","year":"2014","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.085_bib0090","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1365-2222.2008.03067.x","article-title":"Control of cytokine gene transcription in Th1 and Th2 cells","volume":"38","author":"Bowen","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.biopha.2018.09.085_bib0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.intimp.2017.03.013","article-title":"Radiation-induced decrease of CD8+ dendritic cells contributes to Th1\/Th2 shift","volume":"46","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"23","key":"10.1016\/j.biopha.2018.09.085_bib0100","first-page":"3624","article-title":"[Effect of Jinhuang Fuzheng powder on cytokines of immunosuppressive mice with protein antibody micro-array]","volume":"37","author":"Zhu","year":"2012","journal-title":"China J. Chin. Matera Med."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.085_bib0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/jir.2013.0031","article-title":"T helper cell cytokine profiles after endurance exercise","volume":"34","author":"Kakanis","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.085_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2015.05.009","article-title":"Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma","volume":"166","author":"Kennedy","year":"2015","journal-title":"Immunol. Lett."},{"issue":"1-3","key":"10.1016\/j.biopha.2018.09.085_bib0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2012.01.020","article-title":"Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells","volume":"679","author":"Yoon","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.085_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/etm_00000018","article-title":"Alterations in the Th1\/Th2 balance in breast cancer patients using reflexology and scalp massage","volume":"1","author":"Green","year":"2010","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.085_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri2476","article-title":"GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation","volume":"9","author":"Ho","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6282","key":"10.1016\/j.biopha.2018.09.085_bib0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aaf4405","article-title":"Hypoxic control of metastasis","volume":"352","author":"Rankin","year":"2016","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2018.09.085_bib0135","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.085_bib0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1083\/jcb.201212100","article-title":"The hypoxia factor Hif-1alpha controls neural crest chemotaxis and epithelial to mesenchymal transition","volume":"201","author":"Barriga","year":"2013","journal-title":"J. Cell Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221833066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221833066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:33:33Z","timestamp":1777271613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221833066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"alternative-id":["S075333221833066X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.085","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Ginsenoside H dripping pills and cyclophosphamide improve paraneoplastic syndrome and inhibit postoperative recurrence via the reversion of Th1\/Th2 shift","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}